Mice Model Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2028

  • Report ID : 100052
  • Category : Healthcare Technology
  • Pages : -----
  • Reporting status : Published Jan, 19
Allows one Individual to access the Report within an organization
Allows all Employee to access the Report within an organization

Please choose the suitable license type from above.

Buy Now
  • Description
  • Table of Content
  • Research Methodology
  • Related Reports

Mice model has become one of the essential model for dealing with human pathophysiology and disease progression owing to remarkable resemblances between the genetics, anatomy, and physiology mice and humans. These similarities promote mechanisms of different diseases, understanding of the functions of individual genes, scientific discovery, and the effectiveness and toxicities of various drug molecules.

The mouse is the only mammal which offers a rich source for extensive genome manipulation coupled with the potential of genetic diversity, hence evolving as a significant application for modeling human disease. Mouse model shares several features similar with human brain functions such as circadian rhythm, hunger, memory, anxiety, and other emotional responses. New prototypes are technologically advanced where the human tissues and cells are being reconstructed.

Mice Models are widely popular among other animal model owing to their short generation time, small size, low cost, accelerated lifespan, and requirement of less space. One mouse year equals about 30 human years. The genes responsible for operating and building both organs are 90% similar which can help in understanding the mystery of human mental disorders, intelligence and memory related phenomena.

The global market is expected to grow along with the increase in genetic market. Rising demand for personalized medicines and steady increase in R&D of pharmaceutical sectors regarding mice model will positively impact the market. Furthermore, these markets have wider application in the research practices of the various rare diseases, hence aggregating the global demand of the market. rise in monoclonal antibody production has also contributed in the model growth.

Venture capitalists, Clinical Research Organizations (CROs), government and private institutes, medical research centers, mice model & service companies and distributors, animal care products manufacturer, IN &OUT licensing sciences companies (mainly Pharmaceutical, Biotechnology & Biopharmaceuticals), animal healthcare associations, and academic institutes are few consumers producing huge scope for the industry growth over the forecast period. Popularity of humanized mice models, ongoing advancement in mice models and continuous support in terms of investments from the consumers results in market growth.

The global market is categorized as types, services, applications, and technology. The mice model market based on type, is segregated into conditioned/surgically modified mice, genetically engineered mice, outbred mice, spontaneous mutant mice, hybrid/congenic mice, and inbred mice. On the basis of technology, the industry is bifurcated as nuclear transfer, microinjection, CRISPR and embryonic stem cell injection, and others. Other technologies include TALENs & ZFN, DNA electroporation & liposome-mediated DNA, biolistic, virus or vector-mediated gene transfer are also different technology practiced in mice model market.

The industry application includes cardiovascular studies, oncology studies, rare diseases, immunology and inflammation studies, toxicology, diabetes studies, central nervous system studies, hematopoiesis, renal disorders, and others. Based on services, the market is sub-divided into quarantine, surgical, rederivation, line rescue, genetic testing, and others such as breeding, model in-licensing, cryopreservation, and in vivo pharmacology services. Oncology application market is expected to acquire the major share of the industry whereas breeding services from service segment is also expected to contribute majorly to the mice model market.

Geographically, North America region is anticipated to hold the largest share, followed by Asia-Pacific and then Europe. Although, APAC region market is anticipated to grow substantially over the forecast period owing to their well-established pharmaceutical sector and sophisticated biosciences research. Majority of the mice models and transgenic business has been covered by Asia Pacific region particularly in Malaysia, Singapore, China, and India.

The Jackson Laboratory, Charles River Laboratories International Inc., Envigo., Taconic Biosciences, Inc., Laboratory Corporation of America Holdings, Harbour BioMed (China), TRANS GENIC, Inc., JANVIER LABS, genOway, Horizon Discovery Group plc, and JANVIER LABS, are some of the key players in the market. A qualitative analysis of these key players operating globally for mice model market is anticipated to help vendors to generate informed decisions along with being attentive in their industrial operations.

Want to customize this report?

We Can Customize The Report According To Your Need If Listed Report Does Not Meet Your Requirements,Our Research Will Cover All The Businesses Information Required By You.

Please Fill In The Customization Form With Your Requirements.

Help Center

Email Address :

Help Center

Toll Free :+442037693786

More FAQ's